European Investor
05 Aug 2025, 18:20
Hims & Hers Reports Q2 2025 Results: Revenue Jumps 73%, Net Income Hits $42.5M
Hims & Hers Health, Inc. (NYSE: HIMS) reported strong second quarter results, with revenue surging 73% year-over-year to $544.8 million. The company posted net income of $42.5 million and adjusted EBITDA of $82.2 million.
Subscriber count rose 31% to over 2.4 million, with monthly online revenue per subscriber up 30% to $74. The company reaffirmed full-year guidance of $2.3–2.4 billion in revenue and $295–335 million in adjusted EBITDA.
CEO Andrew Dudum highlighted growth momentum and expansion into new health specialties. CFO Yemi Okupe emphasized plans to enhance personalization, lab testing, and global reach.
Hims & Hers Health, Inc. (NYSE: HIMS) reported strong second quarter results, with revenue surging 73% year-over-year to $544.8 million. The company posted net income of $42.5 million and adjusted EBITDA of $82.2 million.
Subscriber count rose 31% to over 2.4 million, with monthly online revenue per subscriber up 30% to $74. The company reaffirmed full-year guidance of $2.3–2.4 billion in revenue and $295–335 million in adjusted EBITDA.
CEO Andrew Dudum highlighted growth momentum and expansion into new health specialties. CFO Yemi Okupe emphasized plans to enhance personalization, lab testing, and global reach.
